Leaflet / SmPC consistency
Identify possible divergences between indications, posology, contraindications, warnings, interactions or adverse effects.
Patient leaflet & SmPC
EryonOne helps compare a patient leaflet and an SmPC, both ways, when the documents are provided as main document and reference.
Benefits
Identify possible divergences between indications, posology, contraindications, warnings, interactions or adverse effects.
Spot complex, ambiguous or overly technical wording to prepare a rewrite by the relevant teams.
Highlight duplicates, contradictions, dosage gaps, incomplete cross-references or sections to review.
Use cases
Limits
EryonOne is an assistant, not a validator. Business responsibility (regulatory, medical, quality, legal) stays with your teams. The report is working material, not an approval.
Frequently asked questions
Yes. EryonOne can help spot discrepancies between a patient leaflet and an SmPC when both documents are provided.
Terminology, posology, contraindications, precautions, adverse effects, storage or missing information.
No. The tool prepares the documentary review, but regulatory validation stays human.
Yes. It is a useful preparatory usage to structure the points to check before internal validation.
Next step
Create an account to launch a first project, or write to us to frame the use case.
Upload your document, pay online, instantly receive a compliance report. Price known upfront, zero commitment.
What AI-assisted review changes for a regulatory affairs team: spot, justify, arbitrate. The decision stays with your team.
MDR by class, IVDR, ANSM doctrine, Directive 2001/83/EC, French Public Health Code: the exact scope of every active framework, and the ones planned next.
Procedures, charters, claim matrices, licensed standards: the sector-by-sector list of documents to upload as requirements in EryonOne.
What is shipped, in progress and planned in EryonOne: dated releases, upcoming work announced by quarter.
Spot the sensitive passages in a health promotional material (claims, benefit/risk balance, consistency with the SmPC) before internal approval.
EryonOne reviews protocols, synopses and investigator brochures: internal consistency, traceability to your references, format and language.